Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [1]
- Immunoprecipitation [2]
- Immunohistochemistry [18]
Submit
Validation data
Reference
Comment
Report error
- Product number
- LS-C784414 - Provider product page
- Provider
- LSBio
- Product name
- CD32A Antibody (clone OTI9G5, Carrier-free) LS-C784414
- Antibody type
- Monoclonal
- Description
- Purified from ascites.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- OTI9G5
- Storage
- Store at -20°C. Avoid freeze-thaw cycles.
No comments: Submit comment
Enhanced validation
- Submitted by
- LSBio (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A.
Supportive validation
- Submitted by
- LSBio (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- Immunoprecipitation(IP) of FCGR2A by using monoclonal anti-FCGR2A antibodies (Negative control: IP without adding anti-FCGR2A antibody.). For each experiment, 500ul of DDK tagged FCGR2A overexpression lysates (at 1:5 dilution with HEK293T lysate), 2 ug of anti-FCGR2A antibody and 20ul (0.1 mg) of goat anti-mouse conjugated magnetic beads were mixed and incubated overnight. After extensive wash to remove any non-specific binding, the immuno-precipitated products were analyzed with rabbit anti-DDK polyclonal antibody.
- Submitted by
- LSBio (provider)
- Main image
- Experimental details
- Immunoprecipitation(IP) of FCGR2A by using monoclonal anti-FCGR2A antibodies (Negative control: IP without adding anti-FCGR2A antibody.). For each experiment, 500ul of DDK tagged FCGR2A overexpression lysates (at 1:5 dilution with HEK293T lysate), 2 ug of anti-FCGR2A antibody and 20ul (0.1 mg) of goat anti-mouse conjugated magnetic beads were mixed and incubated overnight. After extensive wash to remove any non-specific binding, the immuno-precipitated products were analyzed with rabbit anti-DDK polyclonal antibody.
Enhanced validation
- Submitted by
- LSBio (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- IHC of paraffin-embedded colon tissue using anti-FCGR2A mouse monoclonal antibody. (Dilution 1:50).
- Submitted by
- LSBio (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- IHC of paraffin-embedded colon tissue using anti-FCGR2A mouse monoclonal antibody. (Dilution 1:50).
- Submitted by
- LSBio (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- IHC of paraffin-embedded Adenocarcinoma of colon tissue using anti-FCGR2A mouse monoclonal antibody. (Dilution 1:50).
- Submitted by
- LSBio (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- IHC of paraffin-embedded Kidney tissue using anti-FCGR2A mouse monoclonal antibody. (Dilution 1:50).
- Submitted by
- LSBio (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- IHC of paraffin-embedded lung tissue using anti-FCGR2A mouse monoclonal antibody. (Dilution 1:50).
- Submitted by
- LSBio (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- IHC of paraffin-embedded pancreas tissue using anti-FCGR2A mouse monoclonal antibody. (Dilution 1:50).
- Submitted by
- LSBio (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- IHC of paraffin-embedded endometrium tissue using anti-FCGR2A mouse monoclonal antibody. (Dilution 1:50).
- Submitted by
- LSBio (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- IHC of paraffin-embedded prostate tissue using anti-FCGR2A mouse monoclonal antibody. (Dilution 1:50).
- Submitted by
- LSBio (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- IHC of paraffin-embedded Carcinoma of prostate tissue using anti-FCGR2A mouse monoclonal antibody. (Dilution 1:50).
- Submitted by
- LSBio (provider)
- Main image
- Experimental details
- IHC of paraffin-embedded breast tissue using anti-FCGR2A mouse monoclonal antibody. (Dilution 1:50).
- Submitted by
- LSBio (provider)
- Main image
- Experimental details
- IHC of paraffin-embedded colon tissue using anti-FCGR2A mouse monoclonal antibody. (Dilution 1:50).
- Submitted by
- LSBio (provider)
- Main image
- Experimental details
- IHC of paraffin-embedded Adenocarcinoma of colon tissue using anti-FCGR2A mouse monoclonal antibody. (Dilution 1:50).
- Submitted by
- LSBio (provider)
- Main image
- Experimental details
- IHC of paraffin-embedded Kidney tissue using anti-FCGR2A mouse monoclonal antibody. (Dilution 1:50).
- Submitted by
- LSBio (provider)
- Main image
- Experimental details
- IHC of paraffin-embedded lung tissue using anti-FCGR2A mouse monoclonal antibody. (Dilution 1:50).
- Submitted by
- LSBio (provider)
- Main image
- Experimental details
- IHC of paraffin-embedded pancreas tissue using anti-FCGR2A mouse monoclonal antibody. (Dilution 1:50).
- Submitted by
- LSBio (provider)
- Main image
- Experimental details
- IHC of paraffin-embedded endometrium tissue using anti-FCGR2A mouse monoclonal antibody. (Dilution 1:50).
- Submitted by
- LSBio (provider)
- Main image
- Experimental details
- IHC of paraffin-embedded prostate tissue using anti-FCGR2A mouse monoclonal antibody. (Dilution 1:50).
- Submitted by
- LSBio (provider)
- Main image
- Experimental details
- IHC of paraffin-embedded Carcinoma of prostate tissue using anti-FCGR2A mouse monoclonal antibody. (Dilution 1:50).